OnBioVC

Your Source for BioScience Venture Capital Data
Lijit Search

  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru DEC 2009
    - OnBioVC 2009 Year-in-Review, now available
    - OnBioVC 1Q10 Trend Analysis, coming soon

  • SEARCH THE OnBioVC DATABASE:

  • business strategy life science

15

Jun

2009

Opsona Therapeutics, Ltd.: Series B $4.6M

Posted in I - Series B, Q - 2Q09, R - INTERNATIONAL, X - Autoimmune, X - Inflammation, X - Toll Receptor

Opsana Therapeutics (Ireland) a preclinical-stage small molecule company focused on autoimmune and inflammatory disease through toll-like receptor modulators closed a $4.6M Series B financing, bringing the total round to $27.5M. Participants include Roche Venture Fund, Enterprise Ireland, Novartis Venture Fund, Fountain Healthcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences.

24

Feb

2009

Opsona Therapeutics, Ltd.: Series B $22.9M

Posted in I - Series B, Q - 1Q09, R - INTERNATIONAL, X - Autoimmune, X - Inflammation, X - Toll Receptor

Opsana Therapeutics (Ireland) a preclinical-stage small molecule company focused on autoimmune and inflammatory disease through toll-like receptor modulators closed a $22.9M Series B financing. Participants include Novartis Venture Funds, Fountain Healthcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences.

  

to top of page...


 

© 2009 OnBioVC An Indicium Data, LLC Company powered by WordPress